ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (3)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Senn, O.
Right arrow Articles by Probst-Hensch, N. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Senn, O.
Right arrow Articles by Probst-Hensch, N. M.
Eur Respir J 2005; 26:909-917
Copyright ©ERS Journals Ltd 2005

{alpha}1-Antitrypsin deficiency and lung disease: risk modification by occupational and environmental inhalants

O. Senn1, E. W. Russi2, M. Imboden1 and N. M. Probst-Hensch1

1 Dept of Molecular Epidemiology/Cancer Registry, University of Zurich, and 2 Dept of Pneumology, University Hospital of Zurich, Zurich, Switzerland.

CORRESPONDENCE: N. M. Probst-Hensch, Dept of Molecular Epidemiology/Cancer Registry, University of Zurich, Vogelsangstrasse 10, 8091 Zurich, Switzerland. Fax: 41 442555636. E-mail: nicole.probst{at}usz.ch

Keywords: {alpha}1-Antitrypsin, {alpha}1-antitrypsin deficiency, gene–environment interaction, occupational disorder, occupational exposure, passive smoking

Received: February 24, 2005
Accepted June 9, 2005

Chronic obstructive pulmonary disease (COPD) is a prevalent and preventable disease associated with high morbidity and mortality. Severe and intermediate {alpha}1-antitrypsin (AAT) deficiency (serum levels <11 and 11–20 µmol·L–1, respectively) increase the risk of COPD in active smokers. However, little is known about the interaction of severe and intermediate AAT deficiency with modifiable COPD risk factors other than active smoking.

In this study, a MEDLINE search was carried out for studies investigating the combined effect of environmental inhalants (occupation and passive smoking) and AAT deficiency in the lung. A total of 18 studies using established methods for the assessment of AAT deficiency were included in this review.

Occupational exposures and passive smoking affected lung function decline or prevalence of respiratory symptoms in four out of five studies investigating subjects with severe AAT deficiency, and in eight out of 13 studies with a focus on intermediate AAT deficiency. While study designs mostly prohibited formal assessment of effect modification, an interaction between intermediate AAT deficiency and passive smoking was identified in two studies with children. Additional study limitations included small sample size, poor adjustment for confounding and misclassification of environmental exposure as well as AAT activity.

In conclusion, population-based epidemiological studies with associated biobanks are needed to identify gene–environment interactions and population subgroups susceptible to {alpha}1-antitrypsin deficiency.




This article has been cited by other articles:


Home page
CarcinogenesisHome page
D. M.v. Leeuwen, E. v. Agen, R. W.H. Gottschalk, R. Vlietinck, M. Gielen, M. H.M.v. Herwijnen, L. M. Maas, J. C.S. Kleinjans, and J. H.M.v. Delft
Cigarette smoke-induced differential gene expression in blood cells from monozygotic twin pairs
Carcinogenesis, March 1, 2007; 28(3): 691 - 697.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the European Respiratory Society.